Concepedia

Lina Degenfeld‐Schonburg

LD

Statistics

Publications

3

Citations

75

H-Index

3

Active since

2021

Affiliations

Medical University of Vienna(Current)

University Hospital Heidelberg

Ludwig Boltzmann Institute for Cancer Research

Sorbonne Université

University Medical Centre Mannheim

Lina Degenfeld‐Schonburg is an author at Medical University of Vienna specializing in pharmacology, mast cell stabilizer therapy, and allergy pharmacotherapy.

ORCID

Publications per year

2021–2023

3

Publications

3

Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing <i>BCR-ABL1</i> <sup>T315I</sup>-compound mutations.

Karoline V. Gleixner, Yüksel Filik, Daniela Berger et al. · PubMed · 2021 · 41 citations · Full text

, , +13

Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?

Peter Valent, Cem Akin, Karin Hartmann et al. · Journal of Allergy and Clinical Immunology · 2022 · 24 citations · Full text

, , +17

Antineoplastic efficacy profiles of avapritinib and nintedanib in <i>KIT</i> D816V<sup>+</sup> systemic mastocytosis: a preclinical study.

Lina Degenfeld‐Schonburg, Susanne Gamperl, Gabriele Stefanzl et al. · PubMed · 2023 · 10 citations · Full text

, , +17

1–3 of 3